4//SEC Filing
ALBANY MOLECULAR RESEARCH INC 4
Accession 0001179110-14-003575
CIK 0001065087operating
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:22 PM ET
Size
8.2 KB
Accession
0001179110-14-003575
Insider Transaction Report
Form 4
Nolan Michael M
VP, CFO and Treasurer
Transactions
- Exercise/Conversion
Common Stock
2014-02-24$3.43/sh+15,000$51,450→ 91,093 total - Exercise/Conversion
Options to purchase Common Stock
2014-02-24$3.43/sh−15,000$51,450→ 85,000 totalExercise: $3.43Exp: 2022-09-17→ Common Stock (15,000 underlying) - Sale
Common Stock
2014-02-24$15.00/sh−15,000$225,000→ 76,093 total
Footnotes (1)
- [F1]Time based grant which vests 25% per year on each of the first 4 anniversaries of the date of the grant (September 17, 2012). The 15,000 shares being exercised represent a portion of the grant which vested on the first anniversary of the grant date. The remaining 75% of the grant is not yet exercisable.
Documents
Issuer
ALBANY MOLECULAR RESEARCH INC
CIK 0001065087
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001065087
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:22 PM ET
- Size
- 8.2 KB